Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | CTH | P32929 | 1/20 | 0.30 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21419974 | 0.82 | RIPK1 (0.34) | RIPK1 | |
| SCHEMBL19303393 | 0.81 | RIPK1 (0.46) | CA12CA1CA2CA9CA14 | |
| SCHEMBL3967600 | 0.78 | CA1 (0.38) | CA12CA1CA2CA9CA14 | |
| SCHEMBL19527241 | 0.76 | RIPK1 (0.36) | RIPK1 | |
| SCHEMBL13561305 | 0.76 | CA12 (0.34) | CA12CA1CA2CA9CA14 | |
| SCHEMBL22758126 | 0.74 | SMN1; SMN2 (0.39) | SMN1; SMN2RIPK1 | |
| SCHEMBL30069470 | 0.72 | CA12 (0.33) | CA12CA1CA2CA9CA14 | |
| SCHEMBL21946461 | 0.72 | KDM4C (0.42) | SMN1; SMN2RIPK1 | |
| SCHEMBL12180236 | 0.72 | CNR1 (0.44) | CA14SMN1; SMN2RIPK1 | |
| SCHEMBL68609 | 0.71 | SMN1; SMN2 (0.50) | CA12CA1CA2CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11116211-B2 | Modification of segmented polyurethane properties by copolymerizing with pendant functionalized diols | THE UNIVERSITY OF AKRON (US) | 2021-09-14 | — | — | US | disclosed |
| US-20190297883-A1 | Modification of Segmented Polyurethane Properties by Copolymerizing with Pendant Functionalized Diols | THE UNIVERSITY OF AKRON | 2019-10-03 | — | — | US | disclosed |
| US-20170247506-A1 | BIODEGRADABLE POLYMERS WITH PENDANT FUNCTIONAL GROUPS ATTACHED THROUGH AMIDE BONDS | THE UNIVERSITY OF AKRON | 2017-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190297883-A1 | Modification of Segmented Polyurethane Properties by Copolymerizing with Pendant Functionalized Diols | SMCHD1, PUF60, DNER | CA12 1318/4885CA1 2180/4885CA2 3917/4885 |
| US-11116211-B2 | Modification of segmented polyurethane properties by copolymerizing with pendant functionalized diols | SMCHD1, PUF60, DNER | CA12 1318/4885CA1 2180/4885CA2 3917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.